chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Hives; body rash; mild temperature; This case was reported by a nurse via call center representative and described the occurrence of hives in a 6-month-old female patient who received Flu Seasonal QIV Dresden (Influenza vaccine Quadrivalent 2018-2019 season) (batch number 7E4F4, expiry date 30th June 2019) for prophylaxis.   Co-suspect products included flu seasonal qiv dresden pre-filled syringe device (Fluarix Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   On an unknown date, the patient received the 1st dose of Influenza vaccine Quadrivalent 2018-2019 season and Fluarix Tetra Pre-Filled Syringe Device. On an unknown date, less than 4 months after receiving Influenza vaccine Quadrivalent 2018-2019 season and Fluarix Tetra Pre-Filled Syringe Device, the patient experienced hives, generalized rash and slight temperature. On an unknown date, the outcome of the hives, generalized rash and slight temperature were recovered/resolved.   It was unknown if the reporter considered the hives, generalized rash and slight temperature to be related to Influenza vaccine Quadrivalent 2018-2019 season and Fluarix Tetra Pre-Filled Syringe Device. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Linked case(s) involving the same patient:  US2022AMR062248   Additional Information: GSK Receipt Date: 07-Apr-2022 Reporter's Comments: The reporter stated that the patient reacted to Influenza vaccine quadrivalent, was this Fluarix or Flulaval was not sure but it was in 2018. The patient developed hives, body rash and mild temperature. The reporter wanted to resume vaccinations. The reporter was unable to provide exact date of vaccine or additional details as the vaccines were administered at a different facility The reporter consented to follow up via post. Additional Supportive Information: For tolerance to 2nd dose, refer case US2022AMR062248.; Sender's Comments:  US-GLAXOSMITHKLINE-US2022AMR062248:same reporter
Received vaccine age 2 mos. W/in 24-48 hrs onset drowsiness, feeding poorly-Admitted hosp 8 days after vaccine. Dx encephelopathy. W/up negative incl metabolic screening. EEG, L.P., MRI Brain. Seems to have fully recovered (as of 9-24-09).  10/20/09:  Vaccination Record received, no update indicated to VAERS/rmc
Arm became hard and red. Parent applied ice and gave ADVIL with no relief. Was seen by NP 10/1/16. Placed on KEFLEX for cellulitis.
devel fever, papular red urticarial rash on 2MAY93; bruising on thighs; pt was placed on Atarax; given Pediaprofen & APAP for fever t101 ax;
This case was reported by a healthcare professional nurse practitioner) via a sales representative and described the occurrence of crying uncontrollably in a 2-month-old female subject who was vaccinated with PEDIARIX (GlaxoSmithKline). Concurrent vaccination included pneumococcal vaccines (non-gsk); non-GSK manufacturer; unknown; unknown given on an unspecified date. On an unspecified date the subject received the 1st dose of PEDIARIX (.5 ml, unknown details). On an unknown date, less than one day after vaccination with PEDIARIX (described as "post vaccination, same day"), the subject experienced crying uncontrollably, lethargy, inability to wake up and low grade fever. The reporter was not certain where the subject received the vaccination. At the time of reporting the outcome of the events of crying uncontrollably, lethargy, inability to wake up were was resolved. At the time of reporting, the outcome of the event of low grade fever was not reported and unknown. The healthcare professional documented that the uncontrollable crying lasted 3 to 4 hours and "then fell asleep for 2 days child did not want to wake up to eat."). It was unknown if the immunization series was delayed or discontinued.
Nausea, Headache, Body aches.  No treatment.  Felt better after 24 hours of vaccine.
administration error: pt was given dose that was expired, approximately 24 hours past first puncture. no known adverse reactions.
Fatigue, weakness, all over ach, fevered rash about 6in in diameter that itched, fever, dizziness, felt out of it for a day
I had the first shot on 05/13/2020, on that same day, I started to feel feverish. The next day, I went to work, my chest felt tight and it was hard for me to breathe, I complained to my manager, and I was excused to go home (I took no medicine)  On the morning of the  3rd day of taking the vaccine 05/16/2020, I felt a lot better even though I felt sick the night before.  Then I started feeling something on that evening (05/16/2020) I was in my room and I noticed that something was wrong with me. I decided to take note of what was happening. My left side, right  under my breast, where my heart is located was beating abnormally. It was like it was tapping, fluttering, running, (Like ?tap tap TAP!!!! TAP!!!!!!!! TAP  tap tap tap? ???? ) it felt like a plumpy  fat heart.   This tapping  happened like every 3 minutes. Then it started to hurt. It hurt to my back and my left hand. I could barely move it. It didn?t hurt me like a pain when you cut yourself, the pain was different like an ache. I thought I was having a heart attack, I checked google to see the symptoms of a heart attack, but I didn?t feel all the symptoms so I discarded that thought. I started to cry because the pain was getting more intense. I couldn?t breathe properly too. I went to the pharmacy I took the vaccine, I talked to the customer service because the pharmacy was closed, But they couldn?t help me. They were only customer service. I called my aunt to inform her and she told me to go to Store as they were still opened. I went there to complain, they said they haven?t heard anyone complain about a heart pain and abnormal beating  after taking the vaccine and then the told me to take acetaminophen and aspirin. I went home and took only acetaminophen. I didn?t want to take too much medicine after a vaccine. I felt I would die in my sleep that night because of how intense the pain and heart beat abnormality was. The next morning I felt a little better. The pain only kept coming and going. Even till today 08/24/2020, it still feel it sometimes. Most times I have to change my sitting position for it to stop. It feels tight there. I don?t know I could report this issue, till I spoke to my aunt recently and she said cdc should have an option to report this issue, if I knew I would have reported it a long time. Thank you for your time.
Tolerated the shot fine until 8 days afterward. I started breaking out in hives. I got terrible hives in my armpits, stomach, groin and scalp. The hives got so bad that my throat started closing up, it was difficult to open my mouth wide, or even turn my head side to side and breathing was labored. My scalp was puffy and swollen and so itchy. I?ve never really had hives or an allergic reaction to anything before so this was weird. My grandma had a similar hives reaction after her COVID booster as well and is still experiencing them several months later. It?s been 5 weeks since I started having hives and I am still dealing with them every day, although I?m able to manage them better with -antihistamine medication.
The morning after receiving the vaccine, the patient developed what looked like a skin infection around the inner upper arm (inner bicep area) extending towards the elbow area. No inflammation or swelling around the injection site (deltoid area). Patient followed up with a PCP and was prescribed KEFLEX antibiotic.
Tinnitus. No treatments. ringing started approx. 2 months after 2nd moderna dose and continues today.
Sore arm was a given. But I also had runny nose, sneezing, headache and some dizziness.
While waiting for 15-mins monitoring after getting Johnson&Johnson covid vaccine, he fainted and fell off the chair.  Pharmacy staff rushed to his aid and he regained consciousness within a minute.    He said he was feeling flushed and dizzy.   He said he was having too much anxiety and has had fainting issue with vaccinations/MRI in the past.  His blood pressure was low with high heart rate.  We called 911 and paramedics came immediately.  He was still unstable so the paramedics took him for further evaluation
Fever; Chills; Soreness; Swollen lymph nodes; Fatigue; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 16Apr2021 at 13:15 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included high blood pressure. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medications included unknown blood pressure medication and vitamins both for unknown indication and form unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 19Mar2021 at 16:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. On 16Apr2021 at 18:30 the patient experienced fever, chills, soreness, swollen lymph nodes and fatigue. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the events fever, chills, soreness, swollen lymph nodes and fatigue were not resolved at the time of this report.  No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Coughing immediately after vaccination. Coughing led to stridor and respiratory distress. Within one minute, the adverse event was recognized as anaphylaxis. 1 dose of epi-junior was administered in her left thigh. Over the next five minutes patient's respirations returned to normal with a slight cough and occasional stridor when crying.
After the first dose, developed a skin rash behind the knee. With the second dose I have a skin rash in multiple places and an inflamed lymph gland under my right arm.
Had immunizations at wcc visit on 01/25/10, the following day the injection sites were red, today the skin surrounding inj sites on the anterior thighs is red, hard, warm to touch and measures about 3" wide by 1 1/2". Treated with KEFLEX.
for some reason, under my right arm, my right armpit is swollen; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non-HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (BNT162B2), administered in arm right, administration date 18Sep2021 (Batch/Lot number: unknown) as dose 1, single for covid-19 immunization. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: LYMPHADENOPATHY (non-serious) with onset 18Sep2021, outcome "unknown", described as "for some reason, under my right arm, my right armpit is swollen".  Additional information: After first dose of Pfizer COVID-19 vaccination last Saturday 18Sep2021:   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
Patient had an immediate reaction following the 1st Moderna COVID-19 Vaccine administration on 01/18/2021. S/S began immediately following the injection, and were scratchy, dry throat, dry cough, slight wheezing in upper bilateral lobes. Treated with 50 mg Benadryl, monitored for 30 minutes which included vital signs. Patient recovered- home with husband. Advised patient to follow up immediately with urgent care or primary care physician.
Erythema and tenderness at injection site for 4 days. On the 4th day  a neuritis tingling and pain were noted proximal to the injection site.  On the 6th day eruption of a vesicular rash occurred. Currently this has descended, in a milder form, to the wrist area.
This spontaneous report as received from internet referred to a female student (patient) of unknown age. On an unknown date the patient was vaccinated with GARDASIL (Lot#, dose/frequency, route and duration were unspecified). Patient who was taken to hospital, said she thought she might pass out or vomit after she was vaccinated. At the time of reporting the outcome and relationship were unknown. But "authorities believed the reactions were likely to be related to having an injection not the vaccine itself." This is one of several reports that received from the same source. Additional information is not expected.
Rash; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of RASH (Rash) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced RASH (Rash). At the time of the report, RASH (Rash) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.
SHOULDER PAIN, SMELL AND TASTE AGAIN; BODY ACHE; ACHY; FEVER; HEADACHE; NAUSEA; This spontaneous report received from a patient concerned a female of unspecified age. The patient's height, and weight were not reported. The patient's past medical history included runny nose, and congestion, and concurrent conditions included alcohol use, and non-smoker, and other pre-existing medical conditions included the patient had no known drug allergies and there was no history of drug abuse/illicit drug use. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-MAR-2021 to Left Arm for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 11-MAR-2021, the subject experienced body ache. On 11-MAR-2021, the subject experienced achy. On 11-MAR-2021, the subject experienced fever. On 11-MAR-2021, the subject experienced headache. On 11-MAR-2021, the subject experienced nausea. On an unspecified date, the subject experienced shoulder pain, smell and taste again. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from body ache, achy, fever, headache, nausea, and shoulder pain, smell and taste again on 12-MAR-2021. This report was non-serious.
The participant believed the nurse administered the shot too high up on her arm. They said the shot burned more than normal at the time of injection. The participants has had problems since the shot. The arm ached fro about 2 weeks after the shot, then started to become more painful. The participant has had trouble sleeping because of the pain. The participant has seen doctors and physical therapists for the issue. A Quest medical director has reached out the participant and referred her back to her personal physician and gave information on the National Vaccine Injury Compensation Program.
Patient developed symptoms of MISC on 2/21/22; fevers began on 2/24/22 with a Tmax of 40.0 degrees Celsius.  Over the course of illness, symptoms and complications included fevers, sinus tachycardia, hypotension, shock, AKI, abdominal pain, vomiting, diarrhea, rash, mucocutaneous lesions/conjunctivitis, headache, neck pain, and myalgias. Abnormal labs included elevated troponin, elevated NT-ProBNP, elevated creatinine, thrombocytopenia, elevated CRP, and elevated ferritin. Studies showed coronary artery dilatation, left ventricular dysfunction, right ventricular dysfunction, moderate mitral regurgitation, mild tricuspid regurgitation, mildly dilated IVC, and mildly dilated left ventricle. Abdominal imaging showed periportal edema, pericholecystic fluid, small ascites, and gallbladder wall thickening. Patient was admitted to the hospital on 2/25/22 and treated with norepinephrine, IVIG, infliximab, and aspirin. He was in the ICU from 2/25/22 to 2/26/22. He was discharged on 3/1/22.
dose of improperly stored PROQUAD (Lot S013712 Exp 11/1/2020) was administered to a patient; This spontaneous report was received from a registered nurse and refers to a patient of unknown age and gender. No information about the patient's pertinent medical history, concomitant medications and drug reactions or allergies was provided.  On 15-JAN-2020, the patient was vaccinated with a dose of improperly stored measles, mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) 0.5 ml, lot # S013712 with expiration date of 01-NOV-2020, for prophylaxis. The sterile diluent used to reconstitute mumps, rubella and varicella (oka-merck) virus vaccine live (PROQUAD) was properly stored.   It was stated that the vaccine underwent a temperature excursion of -12.2°C (degrees Celsius) for 25 minutes. No previous temperature excursion was done. The call was because of a "data logger".
severe mentrual cramping now for two months in a row ( I haven't had severe mentrual cramping since by ablation several years ago)
Developed tinnitus in my right ear that has not gone away. Onset of that condition happened around April 26-27. I do not normally have this condition. Also, received allergy shots in each arm since my vaccination, and both have resulted in large welt and subsequent bruising which has not occurred in the past year of having the same injections.
Beginning a week after the flu vaccination, I experienced arthritis-like pain in the upper left arm and shoulder. About a month after the vaccination the pain spread to tenderness in the joints of my left thumb. I have no history of prior arthritic pain.
Patient reports a rash from the first shingles shot on her chest and back. The second shot (the one that is being reported) caused adverse reactions including fainting, vomiting, and excessive lethargy including sleeping for about 3/4 of the day following the immunization. The rash was present for the second immunization as well, and the patient reports her skin aching to touch. Patient reported the event to her prescriber, and after sleeping through the night 10/30 felt better.
8 days nauseous every 4 hrs or so, dizzy then too, roof of mouth behind teeth burned, metallic taste in mouth, couldn't taste drinks normally, fever on and off.  I've had a few days clear now so I think it's over. I asked for Tdap so could be around new baby in family-looks like gave me something else. One place form says Tdap other place DTP DTaP wonder if not wrong one for adults since no one else had reaction in family and I usually don't. Confusing form from pharmacy (just now looking at it).
now  throat started to become sore; persistent, horrible headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (persistent, horrible headache) and OROPHARYNGEAL PAIN (now  throat started to become sore) in a 37-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 21-Jun-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jun-2021, the patient experienced HEADACHE (persistent, horrible headache). On 24-Jun-2021, the patient experienced OROPHARYNGEAL PAIN (now  throat started to become sore). The patient was treated with IBUPROFEN at a dose of 1 dosage form. At the time of the report, HEADACHE (persistent, horrible headache) and OROPHARYNGEAL PAIN (now  throat started to become sore) outcome was unknown.             No concomitant medication was reported. Action taken with mRNA-1273 (Moderna COVID-19 Vaccine) was not applicable.
Tinnitus\ ringing in both ears; This spontaneous case was reported by a consumer and describes the occurrence of TINNITUS (Tinnitus\ ringing in both ears) in a 63-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 027A21A and 031L20A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included LEVOTHYROXINE SODIUM (SYNTHROID) and ROSUVASTATIN CALCIUM (CRESTOR) for an unknown indication.   On 11-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 11-Mar-2021, the patient experienced TINNITUS (Tinnitus\ ringing in both ears). At the time of the report, TINNITUS (Tinnitus\ ringing in both ears) outcome was unknown. Not Provided          Treatment information was not provided.
Employee was vaccinated at 4PM on 12/23. Hives started to develop on 12/23 at 8PM. Employee came back to the vaccination site  at 1:15am on 12/24, complaining of hives on trunk of body and arms. No hives on legs or face. Denies shortness of breath , just itching and hives. 50 MG of Benadryl given IM at 1:30am on 12/24 and instructed to go to ER. Employee refused ER attention.
fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (fatigue) and HEADACHE (headache) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030AZ1A) for COVID-19 vaccination.     Concurrent medical conditions included Breast cancer and Rheumatoid arthritis. Concomitant products included LETROZOLE for Cancer, LEVOTHYROXINE and VITAMIN D NOS for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): In March 2021, SARS-CoV-2 test: negative (Negative) Negative.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment medication was provided by the reporter.   This case was linked to MOD-2021-047858 (Patient Link).
No known adverse reaction. Patient given Kinrix and not in correct age range.  Patient met minimum interval requirements between doses. She has had two previous doses of DTaP and two previous doses of Polio.
fever; erythema nodosum; recvd flu vax twice previously w/o adverse effects;
The patient was seen for swelling and redness at the injection site 24 hours after the injection. The area of redness was 5cm in diameter. The patient's temperature was 99.6F. The patient was treated with Tylenol and ice.
Small bumps originating on arm with injection and within a day moved to torso and other arm. Went from wrist to neck, belly all the way to chest.  Side effects did not go away for two weeks until  I used oral benedryl and topical cortisone 10 multiple times per day for about 7 days in a row.
Received vaccine on Aug. 2. First noticed right lower chest pain two days later. Went to Urgent Care for worsening pain evaluated with chest XRAY and told it was inflammation, sent home with antibiotics. No improvement in symptom, worsening pain over time. Started having leg pain last week 9/21/2021. Went to emergency room that day, was diagnosed with deep vein thrombosis and pulmonary embolism.  Started on blood thinners but not admitted.